These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

676 related items for PubMed ID: 10515300

  • 1. Cannabis: discrimination of "internal bliss"?
    Wiley JL.
    Pharmacol Biochem Behav; 1999 Oct; 64(2):257-60. PubMed ID: 10515300
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats.
    Wiley JL, Ryan WJ, Razdan RK, Martin BR.
    Eur J Pharmacol; 1998 Aug 21; 355(2-3):113-8. PubMed ID: 9760024
    [Abstract] [Full Text] [Related]

  • 5. Nicotinic facilitation of delta9-tetrahydrocannabinol discrimination involves endogenous anandamide.
    Solinas M, Scherma M, Tanda G, Wertheim CE, Fratta W, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Jun 21; 321(3):1127-34. PubMed ID: 17351107
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE, Beninger RJ.
    Life Sci; 1998 Jun 21; 62(26):2431-9. PubMed ID: 9651110
    [Abstract] [Full Text] [Related]

  • 8. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
    Wiley JL, Owens RA, Lichtman AH.
    Curr Top Behav Neurosci; 2018 Jun 21; 39():153-173. PubMed ID: 27278640
    [Abstract] [Full Text] [Related]

  • 9. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide.
    Mallet PE, Beninger RJ.
    Psychopharmacology (Berl); 1998 Nov 21; 140(1):11-9. PubMed ID: 9862397
    [Abstract] [Full Text] [Related]

  • 10. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ, Muñoz RM, Romero J, Villanua MA, Makriyannis A, Ramos JA.
    Biochem Pharmacol; 1997 Jun 15; 53(12):1919-27. PubMed ID: 9256167
    [Abstract] [Full Text] [Related]

  • 11. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
    Romero J, García L, Fernández-Ruiz JJ, Cebeira M, Ramos JA.
    Pharmacol Biochem Behav; 1995 Aug 15; 51(4):731-7. PubMed ID: 7675852
    [Abstract] [Full Text] [Related]

  • 12. Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats.
    Bruijnzeel AW, Qi X, Guzhva LV, Wall S, Deng JV, Gold MS, Febo M, Setlow B.
    PLoS One; 2016 Aug 15; 11(4):e0153327. PubMed ID: 27065006
    [Abstract] [Full Text] [Related]

  • 13. Cannabinoid receptors and their endogenous agonist, anandamide.
    Axelrod J, Felder CC.
    Neurochem Res; 1998 May 15; 23(5):575-81. PubMed ID: 9566594
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR.
    J Pharmacol Exp Ther; 2007 Apr 15; 321(1):370-80. PubMed ID: 17210800
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cannabinoid-induced hypotension and bradycardia in rats mediated by CB1-like cannabinoid receptors.
    Lake KD, Compton DR, Varga K, Martin BR, Kunos G.
    J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1030-7. PubMed ID: 9190833
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.